$NOUV Comprehensive DD Confirms Reverse Merger with Entuit

New Post Public Reply Private Reply Replies (0) Message Board
Wolverine19
97
$NOUV Comprehensive DD Confirms Reverse Merger with Entuit Incorporation.

In my opinion, we are about to see a massive move with $NOUV because there are a lot of PR/NEWS upcoming very soon...imminent to be realistic.
PR/NEWS includes but not limited to Completion of the Reverse Merger, OTCMarkets Pink Current Status (2/08/2017), Financials, Shareholder updates, etc.

A very good base has formed @ 0.002 pps. The low float allows $NOUV to make massive gains fast. This is a great time to get in before the News/PR hits the wire.

The Comprehensive DD is below.
$NOUV – REVERSE MERGER with ENTUITINC
Recent OTCMarkets Filings CONFIRMS this!!!

Jeffrey Burns is the CEO of Entuit Incorporated. He is listed as the CEO of NOUV on OTCMarkets and NVSOS Filings. He is also in all the filings for NOUV to become current with OTCMarkets. All of this is confirmation that the Merger has taken place.

OTC PINK CURRENT a/o 2/08/2017
http://www.otcmarkets.com/market-activity/otc...ype=symbol

Verified Company Profile as of 1/26/2017
http://www.otcmarkets.com/stock/NOUV/profile

Merging Company is ENTUITINC , the website is
http://www.entuitinc.com/

NOUV Security Details:
Market Value: $9,134,999 a/o Feb 27, 2017
LOW Float 147,462,475 a/o Mar 31, 2012
http://www.otcmarkets.com/stock/NOUV/profile

Nevada Secretary of State (NVSOS ) Status – ACTIVE
Officers Updated:
Jeffrey Burns – President, Treasurer, Director
Greg Chapman – Secretary
http://nvsos.gov/sosentitysearch/CorpDetails....&nt7=0

Attorney Letter with Respect to Current Information (1-31-2017)
http://www.otcmarkets.com/financialReportView...;id=165832

4) Issuance History Control shares (10% or more)
A. The nature of each offering (e.g., Securities Act Rule 504, intrastate, etc.); The shares issued by the Company were issued in accordance with the Securities & Exchange Act section 4(2). Per the terms and conditions of the Agreement and plan of Merger dated December 16, 2016 , the following former shareholders of Entuit Incorporated were issued 125,000,000 million shares of the Company’s restricted stock.
Susan Burns - 63,750,000
741 Orange Avenue
Daytona, FL 32114
Jeffrey Burns -
61,250,000
741 Orange Avenue
Daytona, FL 32114
http://www.otcmarkets.com/financialReportView...;id=165515

10 filings with OTCMarkets since Jan 25, 2017
http://www.otcmarkets.com/stock/NOUV/filings

• As of December 31, 2016, there were no trading
suspensions, stock splits, dividends, recapitalizations , etc.
• Principal products or services, and their markets;
The Company is a leading developer of hardware solutions for the Municipal Lighting, Building Automation, HVAC, Indoor Lighting, Sub-metering and many other applications. We offer a complete line of wireless control units which fills a unique niche in building automation and energy consumption.
Our products encompass inside and outside lighting, HVAC, advanced metering and various other building automations requirements. The versatility of our system allows all your building needs to be brought under one platform, eliminating the need for several software packages. We provide wireless solutions for Lon Works, BAC Net, Mod Bus and Ethernet. We utilize the Tridium JACE, Niagara Language and Sedona for many of our solutions.

Insiders own 76% of Shares
• Beneficial Shareholders of Greater than Five Percent (5%) is 76%
Oxford Industrial Group Inc - 54%
Mizata, Inc. - 22%
http://www.otcmarkets.com/financialReportView...;id=165515

Entuit’s Client list includes:
Fort Hood
Fort Benning
Fort Bragg
Fort Irwin
Charleston Air Force Base
Department of Energy
Busch Gardens – Tampa Bay
City of Atlantis, Bahamas
SeaWorld Adventure Parks
Macerich
Ahold
Stop&Shop
Westfield
City of Sarasota
SUNY – The State University of New York
Jefferson Lab
Turnberry Associates
Seneca – Nation of Indians
Albion Correctional Facility, NY
Comfort Inn
The Fair – The Great New York State Fair
Publix
Stor-All Storage
Gleneagles Country Club
SAIC
895746451_entuitclients1.jpg
784482548_entuitclients1.jpg

Green Building Partners, LLC is in partnership with ENTUITINC.
http://www.entuitinc.com/greenbldpartners/

Green Building Partners, LLC' Clients:
SUNY – The State University of New York
SUNY Oneonta – Physical Science Building
SUNY Binghamton – Engineering & Science Building
SUNY Plattsburgh – Hudson Hall
SUNY Binghamton – Center of Excellence Building
SUNY Oswego – Park Hall
City of New York Department of Education
Rochester Genesee Regional Transportation Authority
Energy Modeling Study Point of Use Control of HVAC / lighting / plug loads
The Pines Health Care
1286197613_gbp1.jpg
153712303_gbp2.jpg
This partnership adds to ENTUITINC's financials.

For those of you that are concerned about the "caveat emptor" symbol with NOUV...it is not because of the new merging company. The "caveat emptor" symbol was designated to the previous company before Entuit Incorporated's Reverse Merger.
The "Caveat Emptor" symbol will be removed 30 days following current status of
NOUV. 30 business days from Pink Current Status is 3-10-2017. Look for the symbol to be removed and PR/NEWS from the CEO (Jeffrey Burns).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading